Inhaled ipratropium bromide has the following advantages<u> except</u>

A) It does not alter respiratory secretions B) It does not depress airway mucociliary clearance C) It has faster onset of bronchodilator action than inhaled salbutamol D) It only rarely produces systemic side effects